CATALOGO DEI PRODOTTI DELLA RICERCA

BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.859
EU - Europa 8.155
AS - Asia 6.272
SA - Sud America 955
Continente sconosciuto - Info sul continente non disponibili 243
AF - Africa 228
OC - Oceania 23
Totale 27.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.407
RU - Federazione Russa 2.871
SG - Singapore 2.705
GB - Regno Unito 2.025
CN - Cina 1.458
IT - Italia 889
BR - Brasile 770
HK - Hong Kong 557
VN - Vietnam 515
DE - Germania 450
FR - Francia 414
SE - Svezia 409
FI - Finlandia 356
IE - Irlanda 296
KR - Corea 283
BD - Bangladesh 254
CA - Canada 209
UA - Ucraina 125
NL - Olanda 84
IN - India 83
AR - Argentina 69
MX - Messico 63
JP - Giappone 60
NG - Nigeria 58
TR - Turchia 58
ID - Indonesia 54
PK - Pakistan 49
ZA - Sudafrica 44
AT - Austria 36
BJ - Benin 36
IQ - Iraq 33
BE - Belgio 32
CR - Costa Rica 29
CO - Colombia 27
PL - Polonia 26
EC - Ecuador 25
ES - Italia 25
SV - El Salvador 25
HN - Honduras 23
UZ - Uzbekistan 23
CW - ???statistics.table.value.countryCode.CW??? 20
AU - Australia 19
NI - Nicaragua 19
SA - Arabia Saudita 17
VE - Venezuela 17
TT - Trinidad e Tobago 16
EG - Egitto 15
CL - Cile 14
GT - Guatemala 14
PH - Filippine 14
GR - Grecia 13
LT - Lituania 12
PR - Porto Rico 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
IL - Israele 11
MA - Marocco 11
BG - Bulgaria 10
JM - Giamaica 10
JO - Giordania 10
MY - Malesia 10
RO - Romania 10
TN - Tunisia 10
BO - Bolivia 9
HR - Croazia 9
PY - Paraguay 9
AZ - Azerbaigian 8
EE - Estonia 8
ET - Etiopia 8
GH - Ghana 8
KE - Kenya 8
NP - Nepal 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
GP - Guadalupe 7
PT - Portogallo 7
AL - Albania 6
DO - Repubblica Dominicana 6
IS - Islanda 6
KG - Kirghizistan 6
PE - Perù 6
BB - Barbados 5
CH - Svizzera 5
DK - Danimarca 5
IR - Iran 5
OM - Oman 5
TH - Thailandia 5
KZ - Kazakistan 4
LV - Lettonia 4
TG - Togo 4
TW - Taiwan 4
BS - Bahamas 3
BY - Bielorussia 3
BZ - Belize 3
HU - Ungheria 3
KH - Cambogia 3
LB - Libano 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PA - Panama 3
Totale 27.468
Salva come PNG Salva come JPEG
Città #
Ashburn 1.846
Southend 1.681
Singapore 1.336
San Jose 1.125
Jacksonville 989
Dallas 972
Moscow 915
Woodbridge 740
Chandler 733
Hong Kong 550
Houston 379
Verona 356
Council Bluffs 334
Ann Arbor 318
Dublin 297
The Dalles 287
New York 248
Beijing 225
Los Angeles 185
Ho Chi Minh City 180
Wilmington 143
Lawrence 141
Princeton 141
Santa Clara 119
Buffalo 108
Nanjing 106
Hanoi 102
Sindelfingen 82
Shenyang 81
São Paulo 81
Milan 80
Boardman 79
Redondo Beach 78
Helsinki 72
Munich 66
Jinan 65
London 61
Abuja 52
Tokyo 50
Hebei 47
Amsterdam 45
Columbus 44
Toronto 44
Phoenix 43
Seoul 43
Changsha 42
Chicago 41
Montreal 40
Rome 40
Tianjin 40
San Francisco 37
Annandale 36
Cotonou 36
Nanchang 34
Nuremberg 34
Orem 34
Brussels 31
Falkenstein 30
Frankfurt am Main 30
Zhengzhou 30
Turku 29
Haikou 28
Brasília 27
Hangzhou 26
Atlanta 25
Rio de Janeiro 25
North Bergen 24
Redmond 24
San José 24
San Salvador 24
Washington 24
Ningbo 23
Bologna 22
Brooklyn 22
Warsaw 22
Guangzhou 21
Haiphong 21
Jakarta 21
Johannesburg 21
Belo Horizonte 20
Tashkent 20
Willemstad 20
Da Nang 19
Denver 19
Managua 19
McKinney 19
Naples 18
Philadelphia 18
Stockholm 18
Taiyuan 18
Mianwali 17
Norwalk 17
Shanghai 17
Taizhou 17
Vienna 17
Boston 16
Jiaxing 16
North Hollywood 16
Providence 16
Seattle 16
Totale 17.030
Salva come PNG Salva come JPEG
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 795
Common Variants Associated to Type 2 Diabetes in the Italian Population 509
Adipocytes IGFBP-2 expression in prepubertal obese children. 346
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 273
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 265
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 244
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 243
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 234
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 226
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 223
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 216
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 215
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 214
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 212
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 210
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 207
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 206
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 206
High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents 204
Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 200
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 200
Pathogenesis of NIDDM. A balanced overview. 199
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 199
A compartmental model to quantitate in vivo glucose transport in the human forearm 195
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 193
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 192
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 190
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 190
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 185
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 185
Fat cell size, insulin sensitivity, and inflammation in obese children. 185
Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria 184
Beta-cell function across the spectrum of glucose tolerance in obese youth. 183
Metabolic and hormonal consequences of two different meals after a moderate intensity exercise bout in obese prepubertal children 182
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 182
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 181
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 177
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 175
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 173
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 173
Obesity and insulin resistance in man. A dose response study 172
Operation of Randle's cycle in patients with NIDDM 171
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 171
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 171
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 169
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 169
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 168
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 167
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 167
Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose 166
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. 165
Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. 163
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 163
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 161
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 161
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus 160
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 159
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 157
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 156
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 153
Effect of insulin on system A amino acid transport in human skeletal muscle 152
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 150
Pleiotropic Effects of GIP on Islet Function Involve Osteopontin. 148
Estimation of blood flow heterogeneity in human skeletal muscle using intravascular tracer data: importance for modeling transcapillary exchange 147
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus 147
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 147
In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia 146
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. 144
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 141
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 140
Evaluating endothelial function of the common carotid artery: An in vivo human model. 140
Estimation of blood flow heterogeneity distribution in human skeletal muscle from positron emission tomography data 139
Glucose metabolism in obesity and type 2 diabetes 139
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 138
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 137
Metabolic and thermogenic effects of lactate infusion in humans 137
Time dependence of the interaction between lipid and glucose in humans 137
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 137
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 136
Sintesi di glicogeno, glicolisi ed ossidazione glucidica nel paziente obeso con diabete tipo II. Contributo alla insulinoresistenza. 136
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 136
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 134
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 133
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 133
Platelet and clotting activities after cold stress in diabetic patients 132
Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle 132
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 132
Grasso corporeo totale e grasso regionale: rapporti con il metabolismo "in vivo" del glucosio in donne obese e non obese. 132
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 131
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 131
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 131
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 130
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 130
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 129
Phasic insulin release and metabolic regulation in type 2 diabetes 128
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 127
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 127
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 126
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 126
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 125
Totale 17.903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.380
article - articoli 79.160
book - libri 0
conference - conferenze 11.989
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 231
Totale 182.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022581 0 0 0 0 25 36 9 58 35 36 94 288
2022/20232.142 172 183 225 381 217 473 29 151 200 13 63 35
2023/20241.469 37 95 94 148 143 198 66 356 6 89 154 83
2024/20253.817 180 204 130 678 148 95 216 196 659 222 348 741
2025/202611.021 798 628 967 1.718 2.538 723 1.179 613 654 551 337 315
2026/20272.623 244 336 501 1.494 48 0 0 0 0 0 0 0
Totale 27.735